U.S. federal trademark · Serial No. 76286020
Prescription pharmaceutical product consisting of a combination of amphetamine and dextroamphetamine salts intended for the treatment of Attention Deficit Hyperactivity Disorder - ADHD
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.